Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Supernus Pharmaceuticals Number of Employees 2011-2023 | SUPN

Supernus Pharmaceuticals number of employees from 2011 to 2023. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
  
Supernus Pharmaceuticals Annual Employee Count
2023 652
2022 612
2021 575
2020 563
2019 464
2018 448
2017 422
2016 363
2015 344
2014 309
2013 235
2012 193
2011
2010
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.695B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.551B 19.84
Aspen Pharmacare (APNHY) South Africa $5.574B 0.00
BridgeBio Pharma (BBIO) United States $5.208B 0.00
Bausch Health Cos (BHC) Canada $2.868B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.042B 14.20
Taysha Gene Therapies (TSHA) United States $0.481B 0.00
Generation Bio (GBIO) United States $0.211B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00